LGND – Ligand Pharmaceuticals Incorporated
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
4.87
Margin Of Safety %
38
Put/Call OI Ratio
0.17
EPS Next Q Diff
-0.5
EPS Last/This Y
2.63
EPS This/Next Y
0.51
Price
111.8
Target Price
142.38
Analyst Recom
1.14
Performance Q
4.41
Relative Volume
0.65
Beta
1.06
Ticker: LGND
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | LGND | 113.75 | 0.10 | 0.00 | 1434 |
| 2024-12-20 | LGND | 114.8 | 0.10 | 999.99 | 1433 |
| 2024-12-23 | LGND | 113.53 | 0.13 | 0.40 | 832 |
| 2024-12-24 | LGND | 113.38 | 0.13 | 0.05 | 837 |
| 2024-12-26 | LGND | 114.09 | 0.13 | 0.09 | 858 |
| 2024-12-27 | LGND | 108.96 | 0.13 | 0.36 | 882 |
| 2024-12-30 | LGND | 105.52 | 0.13 | 0.20 | 898 |
| 2024-12-31 | LGND | 106.67 | 0.13 | 0.10 | 898 |
| 2025-01-02 | LGND | 108.18 | 0.12 | 1.00 | 905 |
| 2025-01-03 | LGND | 110.26 | 0.13 | 0.00 | 909 |
| 2025-01-06 | LGND | 107.9 | 0.12 | 0.75 | 921 |
| 2025-01-07 | LGND | 110.56 | 0.12 | 0.23 | 921 |
| 2025-01-08 | LGND | 111.04 | 0.13 | 0.40 | 934 |
| 2025-01-09 | LGND | 110.58 | 0.13 | 0.40 | 934 |
| 2025-01-10 | LGND | 106.32 | 0.13 | 0.00 | 948 |
| 2025-01-13 | LGND | 105.51 | 0.13 | 0.00 | 952 |
| 2025-01-14 | LGND | 108.3 | 0.13 | 0.00 | 954 |
| 2025-01-15 | LGND | 110.09 | 0.13 | 10.00 | 955 |
| 2025-01-16 | LGND | 111.13 | 0.16 | 0.67 | 986 |
| 2025-01-17 | LGND | 111.69 | 0.17 | 0.00 | 986 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | LGND | 113.95 | -14.8 | 21.4 | 5.64 |
| 2024-12-20 | LGND | 114.38 | -14.8 | 22.1 | 5.64 |
| 2024-12-23 | LGND | 113.80 | -14.8 | 21.1 | 5.64 |
| 2024-12-24 | LGND | 113.38 | -14.8 | 21.4 | 5.64 |
| 2024-12-26 | LGND | 114.25 | -14.8 | 22.4 | 5.64 |
| 2024-12-27 | LGND | 109.20 | -14.8 | 17.6 | 5.64 |
| 2024-12-30 | LGND | 105.34 | -14.8 | 18.5 | 5.64 |
| 2024-12-31 | LGND | 106.72 | -14.8 | 22.5 | 5.64 |
| 2025-01-02 | LGND | 108.73 | -14.8 | 23.0 | 5.64 |
| 2025-01-03 | LGND | 110.40 | -14.8 | 23.4 | 5.64 |
| 2025-01-06 | LGND | 107.65 | -14.8 | 19.3 | 5.64 |
| 2025-01-07 | LGND | 110.21 | -14.8 | 23.7 | 5.64 |
| 2025-01-08 | LGND | 110.58 | -14.8 | 21.9 | 5.64 |
| 2025-01-09 | LGND | 110.58 | -14.8 | 21.7 | 5.64 |
| 2025-01-10 | LGND | 106.31 | -14.8 | 18.1 | 5.64 |
| 2025-01-13 | LGND | 105.68 | -14.8 | 21.2 | 5.64 |
| 2025-01-14 | LGND | 108.29 | -14.8 | 23.8 | 5.64 |
| 2025-01-15 | LGND | 110.28 | -14.8 | 23.2 | 5.64 |
| 2025-01-16 | LGND | 110.78 | -14.8 | 22.1 | 5.64 |
| 2025-01-17 | LGND | 111.80 | -14.8 | 22.3 | 5.64 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | LGND | -12.07 | 4.84 | 4.25 |
| 2024-12-20 | LGND | -12.07 | 4.84 | 4.25 |
| 2024-12-23 | LGND | -12.00 | 4.84 | 4.25 |
| 2024-12-24 | LGND | -12.00 | 4.84 | 4.25 |
| 2024-12-26 | LGND | -12.11 | 4.84 | 4.40 |
| 2024-12-27 | LGND | -12.45 | 4.84 | 4.40 |
| 2024-12-30 | LGND | -12.95 | 4.87 | 4.40 |
| 2024-12-31 | LGND | -12.95 | 4.87 | 4.40 |
| 2025-01-02 | LGND | -12.36 | 4.87 | 4.40 |
| 2025-01-03 | LGND | -12.50 | 4.87 | 4.40 |
| 2025-01-06 | LGND | -12.29 | 4.87 | 4.40 |
| 2025-01-07 | LGND | -12.29 | 4.87 | 4.40 |
| 2025-01-08 | LGND | -12.50 | 4.87 | 4.40 |
| 2025-01-09 | LGND | -12.50 | 4.87 | 4.40 |
| 2025-01-10 | LGND | -12.50 | 4.87 | 4.40 |
| 2025-01-13 | LGND | -12.50 | 4.93 | 4.87 |
| 2025-01-14 | LGND | -12.50 | 4.93 | 4.87 |
| 2025-01-15 | LGND | -12.50 | 4.93 | 4.87 |
| 2025-01-16 | LGND | -12.50 | 4.93 | 4.87 |
| 2025-01-17 | LGND | -12.50 | 4.93 | 4.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.84
Avg. EPS Est. Current Quarter
1.18
Avg. EPS Est. Next Quarter
1.34
Insider Transactions
-12.5
Institutional Transactions
4.93
Beta
1.06
Average Sales Estimate Current Quarter
39
Average Sales Estimate Next Quarter
36
Fair Value
154.26
Quality Score
96
Growth Score
70
Sentiment Score
93
Actual DrawDown %
18.4
Max Drawdown 5-Year %
-65.5
Target Price
142.38
P/E
44.52
Forward P/E
18.45
PEG
2.97
P/S
13.87
P/B
2.5
P/Free Cash Flow
28.62
EPS
2.51
Average EPS Est. Cur. Y
5.64
EPS Next Y. (Est.)
6.16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
29.68
Relative Volume
0.65
Return on Equity vs Sector %
-13.7
Return on Equity vs Industry %
-1.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.06
EBIT Estimation
22.3
stock quote shares LGND – Ligand Pharmaceuticals Incorporated Stock Price stock today
news today LGND – Ligand Pharmaceuticals Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch LGND – Ligand Pharmaceuticals Incorporated yahoo finance google finance
stock history LGND – Ligand Pharmaceuticals Incorporated invest stock market
stock prices LGND premarket after hours
ticker LGND fair value insiders trading